Atlas Trials

Comparison Between Fotemustin to Intensive Surveillance in Patients With High Risk Uveal Melanoma

Clinical trial NCT02843386 · COMPLETED

Trial details

NCT number
NCT02843386
Sponsor
Institut Curie
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Uveal Melanoma
Start date
2009-06-23
Primary completion
2020-06-12
Enrollment
302

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.